Dr. Falk Lohoff is a board certified psychiatrist with special interest in psychopharmacology and personalized medicine for the evaluation, diagnosis and treatment of mood and anxiety disorders and addictions. He offers a wide range of treatment options ranging from supportive psychotherapy to medication management to complex multi-drug psychopharmacology and biomarker informed treatment. He is a certified buprenorphine prescriber and uses a variety of pharmacological interventions for the treatment of addictions and their comorbidities.
He received his medical degree from Humboldt University of Berlin Germany and completed residency training in psychiatry at the University of Pennsylvania. He then completed a fellowship in neuropsychopharmacology at the University of Pennsylvania and became Assistant Professor of Psychiatry at the University of Pennsylvania.
Dr. Lohoff’s research focused on clinical trials for the treatment of mood and anxiety disorders as well as research on the genetics of a variety of psychiatric disorders. He has published peer-reviewed articles in areas including bipolar disorder, major depressive disorder, generalized anxiety disorder, addictions and pharmacogenetics.